Veritas India Q1 FY27: PAT -85% YoY to ₹3.66 Cr as margins compress, revenue +53%

Veritas (India) reported consolidated revenue of ₹897.52 Cr for Q1 FY27 (quarter ended June 30, 2026), up 52.99% YoY from ₹586.66 Cr and up 68.80% QoQ from ₹531.74 Cr. Consolidated PAT, however, fell 84.86% YoY to ₹3.66 Cr from ₹24.15 Cr a year ago, even as it recovered sequentially from a ₹15.93 Cr loss in Q4 FY26 — the QoQ swing is a low-base recovery and not the primary signal; the YoY profit collapse against strong revenue growth is. Net profit margin compressed to 0.41% from 4.10% YoY, and EBITDA margin (excluding other income) fell to about 2.24% from 6.11% YoY. The squeeze sits on two lines: finance costs rose 30.7% YoY to ₹5.97 Cr from ₹4.57 Cr, and the Warehousing segment swung to a ₹1.60 Cr loss from a ₹0.98 Cr profit a year ago, even as the dominant Distribution & Development trading segment (₹877.71 Cr, ~98% of revenue) grew but at compressed segment margins (₹11.18 Cr segment profit vs ₹24.94 Cr YoY). Standalone, which is a pure holding entity, booked no revenue from operations this quarter and posted a ₹0.68 Cr loss on ₹0.91 Cr of other income — not comparable to the consolidated operating story and included here only for completeness. No formal management guidance is on record for this company, and no analyst/street estimates for this print turned up in a search — Veritas (India) is a thinly tracked micro-cap with no visible sell-side coverage, so vsGuidance and vsStreet are both unknown rather than beat/miss. No management press release accompanied the results beyond the standard board-outcome letter. The quarter's more significant corporate action was concurrent with the results: the Board gave final approval to dispose of wholly-owned subsidiary Verasco FZE (Dubai) to Inergy FZE, Sharjah, for up to USD 51 million — a unit that contributed ₹66.55 Cr (2.14%) of FY26 consolidated turnover but ₹910.06 Cr (31.77%) of consolidated net worth, making it a balance-sheet-scale event once it completes. Separately, the Board reconfirmed Paresh Merchant as MD and had earlier recommended a ₹0.05/share FY26 dividend (record date August 28, 2026).